drugset / Trial / NCT02946125
Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil
Non-randomizedCrossoverSingle-blindTreatment
Summary
This is a Phase 2 study to investigate the safety, efficacy and pharmacokinetics of EYN-1601 for dilation of the pupil. A single microdose of EYN-1601 will be compared to single doses of commercially available phenylephrine hydrochloride 2.5% and 10% ophthalmic solutions.
Timeline
- Start
- 2016-10
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phenylephrine | Small molecule | 2.5 % | Topical |
| Subject | Phenylephrine | Small molecule | 10 % | Topical |
Indications
No indication recorded.